Gulec A, Turkoglu S, Kocabas R
J Neural Transm (Vienna). 2024; 132(1):157-168.
PMID: 39249516
DOI: 10.1007/s00702-024-02831-w.
Choi E, Rajendiran T, Soni T, Park J, Aring L, Muraleedharan C
Nat Commun. 2024; 15(1):4775.
PMID: 38839750
PMC: 11153611.
DOI: 10.1038/s41467-024-49049-8.
Zhao Y, Zhao H, Li L, Yu S, Liu M, Jiang L
Front Immunol. 2024; 14:1321597.
PMID: 38274826
PMC: 10808295.
DOI: 10.3389/fimmu.2023.1321597.
Nagree M, Rybova J, Kleynerman A, Ahrenhoerster C, Saville J, Xu T
Commun Biol. 2023; 6(1):560.
PMID: 37231125
PMC: 10212955.
DOI: 10.1038/s42003-023-04932-w.
Caputo S, Di Martino S, Cilibrasi V, Tardia P, Mazzonna M, Russo D
J Med Chem. 2020; 63(24):15821-15851.
PMID: 33290061
PMC: 7770833.
DOI: 10.1021/acs.jmedchem.0c01561.
Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain.
Zoicas I, Muhle C, Schmidtner A, Gulbins E, Neumann I, Kornhuber J
Cells. 2020; 9(5).
PMID: 32429522
PMC: 7290887.
DOI: 10.3390/cells9051239.
Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes.
Yuan X, Bhat O, Lohner H, Zhang Y, Li P
Front Cell Dev Biol. 2020; 8:111.
PMID: 32211403
PMC: 7076051.
DOI: 10.3389/fcell.2020.00111.
Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.
Beckmann N, Becker K, Kadow S, Schumacher F, Kramer M, Kuhn C
Int J Mol Sci. 2019; 20(24).
PMID: 31835809
PMC: 6941101.
DOI: 10.3390/ijms20246253.
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Shaw J, Costa-Pinheiro P, Patterson L, Drews K, Spiegel S, Kester M
Adv Cancer Res. 2018; 140:327-366.
PMID: 30060815
PMC: 6320700.
DOI: 10.1016/bs.acr.2018.04.016.
Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C, Norris J, White-Gilbertson S
Adv Cancer Res. 2018; 140:265-293.
PMID: 30060812
PMC: 6460930.
DOI: 10.1016/bs.acr.2018.04.014.
Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload.
Zhang Y, Huang Y, Cantalupo A, Azevedo P, Siragusa M, Bielawski J
JCI Insight. 2016; 1(5).
PMID: 27158676
PMC: 4855879.
DOI: 10.1172/jci.insight.85484.
Novel chemotherapeutic drugs in sphingolipid cancer research.
Canals D, Hannun Y
Handb Exp Pharmacol. 2013; (215):211-38.
PMID: 23579458
PMC: 3998523.
DOI: 10.1007/978-3-7091-1368-4_12.
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity.
Realini N, Solorzano C, Pagliuca C, Pizzirani D, Armirotti A, Luciani R
Sci Rep. 2013; 3:1035.
PMID: 23301156
PMC: 3539145.
DOI: 10.1038/srep01035.
Ceramide function in the brain: when a slight tilt is enough.
Mencarelli C, Martinez-Martinez P
Cell Mol Life Sci. 2012; 70(2):181-203.
PMID: 22729185
PMC: 3535405.
DOI: 10.1007/s00018-012-1038-x.
Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D, Perry D, Jenkins R, Hannun Y
Br J Pharmacol. 2011; 163(4):694-712.
PMID: 21615386
PMC: 3111673.
DOI: 10.1111/j.1476-5381.2011.01279.x.
Potent inhibition of Acid ceramidase by novel B-13 analogues.
Proksch D, Klein J, Arenz C
J Lipids. 2011; 2011:971618.
PMID: 21490813
PMC: 3066644.
DOI: 10.1155/2011/971618.
A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.
Bedia C, Camacho L, Abad J, Fabrias G, Levade T
J Lipid Res. 2010; 51(12):3542-7.
PMID: 20871013
PMC: 2975727.
DOI: 10.1194/jlr.D010033.
Improved synthesis of a fluorogenic ceramidase substrate.
Xia Z, Draper J, Smith C
Bioorg Med Chem. 2010; 18(3):1003-9.
PMID: 20085856
PMC: 2841511.
DOI: 10.1016/j.bmc.2009.12.071.
Molecular targeting of acid ceramidase: implications to cancer therapy.
Zeidan Y, Jenkins R, Korman J, Liu X, Obeid L, Norris J
Curr Drug Targets. 2008; 9(8):653-61.
PMID: 18691012
PMC: 3402562.
DOI: 10.2174/138945008785132358.
Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
Mao C, Obeid L
Biochim Biophys Acta. 2008; 1781(9):424-34.
PMID: 18619555
PMC: 2614331.
DOI: 10.1016/j.bbalip.2008.06.002.